written by reader I placed a topic for discussion last night on a Texas biotech set to release an announcement on CD19

By backoffice, June 16, 2017

on June 23rd that look promising for big returns (according to the offer). I did some investigating and came up with $BLCM,
Bellicum Pharmaceuticals that also has an orphan drug in development. Maybe the Doc can give use some inside on this.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.